Parent Acceptance and Commitment Therapy (PACT) for Parents of Children With Pediatric Feeding Disorder (PACT)

April 12, 2024 updated by: Dana Bakula, Children's Mercy Hospital Kansas City

This is a pilot study of randomized clinical trial of Parent Acceptance and Commitment Therapy (PACT) vs. an attention-control condition (placebo) for improving the mental health of parents of children with pediatric feeding disorder.

The goal of this clinical trial is to compare two programs in parents of children with pediatric feeding disorders.

The main question[s] it aims to answer are:

  • PACT will result in clinically meaningful reductions in Mental Health(MH) problems among parents of children with Pediatric Feed Disorder (PFD)
  • Identify factors that impact the feasibility of PACT delivery

    • Participants will asked to participate in one of two programs focused on parents of children with pediatric feeding disorders.
    • The participants will also be asked to complete a battery of questionnaires at four timepoints during the study.
    • The parents will be asked to video record a meal time twice during study.

If there is a comparison group: Researchers will compare the PACT group with a control group to see if PACT will result in clinically meaningful change in parent stress and anxiety, and parent use of positive mealtime behaviors.

Study Overview

Detailed Description

The goal of this study is to advance the science of a brief parent mental health intervention for parents of children with pediatric feeding disorder using Parent Acceptance and Commitment Therapy (PACT-F). The ultimate goal of this research is to improve parent mental health and child health and feeding outcomes through a parent-focused behavioral intervention.

PACT-F is a 2-session acceptance and commitment therapy (ACT) intervention guided by Brown and Whittingham's ACT intervention for parents of children with neurodevelopmental conditions. Intervention content is based on principles of ACT, an evidence-based treatment for adult mental health problems. The intervention content is therefore broadly applicable to all parents but was specifically tailored for the needs of parents of children with neurodevelopmental conditions. In study phase 1 of this award, the investigators adapted parent ACT for parents of children with pediatric feeding disorder (PACT-F) with consultation from 2 parents of children with pediatric feeding disorder and 2 experts in parent ACT. The investigators now have a complete treatment package that has been tailored for parents of children with pediatric feeding disorder and is ready to be piloted.

Thus, in this study the investigators will conduct a feasibility and proof-of-concept pilot of a 2-session parent-focused ACT intervention tailored to meet the needs of parents of children with pediatric feeding disorder (PACT-F). The goal of this pilot is to determine factors that impact the success of recruitment, retention, assessment, and treatment delivery for the PACT-F clinical trial and to test the intervention's proof of concept (i.e., does it show a clinically meaningful signal of change in parent mental health). This study will be conducted at a single site (Children's Mercy Hospital). The investigators will pilot the clinical trial procedures and monitor feasibility success, and factors that may impact feasibility success. Participants who meet inclusion criteria will be randomized to either PACT-F or an attention control (control) condition. Participants will be blind to treatment condition (single blind study). The aim of the feasibility analyses is to evaluate factors critical to success, rather than evaluating whether the intervention is "feasible or not feasible". The aim of the proof-of-concept analyses is to determine if this intervention has promise and warrants a larger efficacy trial.

Parents randomized to PACT-F will complete two 90-minute PACT-F sessions individually with a study interventionist, 2 weeks apart. Parents randomized to the control group will complete two 90-minute sessions individually with a study interventionist, 2-weeks apart (focused on nutrition education). The control intervention will be parallel to the ACT intervention in all ways, including interactive components and the face-to-face time with health professionals (interventionists). The control condition intervention has already been developed by Dr. Davis's research team and covers a range of nutrition and healthy lifestyle topics including the United States Department of Agriculture's (USDA) MyPlate. An attention control condition was selected to mimic the interpersonal benefits that may come from meeting individually with a caring professional. The control condition intervention content (healthy lifestyles) was specifically chosen as it most closely reflects the types of information that parents would learn from healthcare professionals about the type of nutrition that their child needs. However, this type of intervention should not impact parent mental health.

Interventionists for both conditions will be individuals with at least master's degree training in mental health or a related field. The interventions will take via tele-video conferencing to allow participants to participate from home without needing transportation to and from the hospital. Both arms of the intervention will be manualized and interventionists in both arms will be trained using didactics and role playing with the Principle Investigator(PI). Intervention fidelity will be monitored by audio/video recording all sessions. The PI (Dr. Bakula) will review recordings each week and conduct separate 1-hour weekly supervision of study interventionists for each arm of the study (PACT-F & control).

Strategies will be used to promote fidelity in line with recommendations from the NIH Behavior Change Consortium. A fidelity checklist will be developed in line with adaptations to the intervention and will be piloted with study interventionists. The fidelity checklist will be refined during research team meetings. The fidelity checklist will be reviewed by the PI during supervision.

Hypothesis testing: The investigators will test the hypothesis that PACT-F results in clinically meaningful change using the Reliable Change Index (RCI; success defined as RCI > 1.96). The investigators anticipate that these procedures will be feasible, with feasibility success defined as recruitment rate above 60%, and retention, assessment completion, and intervention completion rate above 80%. Mixed methods data collection will identify factors that impact 1) recruitment rate (qualitative interviews, % meeting inclusion criteria, # of contact attempts), 2) retention rates (qualitative interviews, baseline characteristics; treatment group), 3) assessment completion rate (qualitative interviews, measure type), and 4) treatment completion rate (qualitative interviews, scheduling, treatment location).

The proposed study is an important first step towards developing an evidence-based treatment that can be used with parents of children with pediatric feeding disorder. This intervention has the potential to improve parent mental health, as well as child health, and therefore has the potential to have broad public health impact.

Study Type

Interventional

Enrollment (Actual)

73

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Missouri
      • Kansas City, Missouri, United States, 64108
        • Children's Mercy Hospitals and Clinics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 1) Must be a parent aged 18+ (primary caregiver) of 2-6-year-old child with PFD
  • 2) Child must be receiving outpatient PFD treatment at Children's Mercy Hospital (CMH)
  • 3) The parent must have a clinically significant elevation on at least one measure of parent MH (using established clinical cutoffs). Parents will be included regardless of whether the child has a new diagnosis or established diagnoses

Exclusion Criteria:

  • 1) Parent has significant cognitive impairments
  • 2) Parent does not speak English
  • Parent unable to obtain high speed internet at home

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Parent Acceptance and Commitment Therapy (PACT)
PACT-F is a 2-session intervention based on the Focused Acceptance and Commitment Therapy treatment literature.
PACT is a 2-session intervention based on the Focused Acceptance and Commitment Therapy treatment literature
Active Comparator: Control
The content of the control intervention covers a range of nutrition and healthy lifestyle topics including USDA's MyPlate.
The content of the control intervention covers a range of nutrition and healthy lifestyle topics including USDA's MyPlate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Baseline, 2 weeks post-intervention completion, 3-months post-intervention
A 9-item self-report measure of depressive symptoms
Baseline, 2 weeks post-intervention completion, 3-months post-intervention
General Anxiety Disorder Screener (GAD-7)
Time Frame: Baseline, 2 weeks post-intervention, 3-months post-intervention
A 7-item self-report measure of anxious symptoms
Baseline, 2 weeks post-intervention, 3-months post-intervention
Impact of Event Scale - Revised (IES-R)
Time Frame: Baseline, 2 weeks post-intervention, 3-months post-intervention
A 22-item self-report measure of posttraumatic stress symptoms
Baseline, 2 weeks post-intervention, 3-months post-intervention
Perceived Stress Scale (PSS)
Time Frame: Baseline, 2 weeks post-intervention, 3-months post-intervention
A 10-item self-report measure of perceived stress
Baseline, 2 weeks post-intervention, 3-months post-intervention
The Acceptance and Action Questionnaire (AAQ-2)
Time Frame: Baseline, 2 weeks post-intervention, 3-months post-intervention
A 7-item self-report measure of psychological flexibility and experiential avoidance
Baseline, 2 weeks post-intervention, 3-months post-intervention
Pediatric Quality of Life Inventory (PedsQL)
Time Frame: Baseline, 2 weeks post-intervention, 3-months post-intervention
A 23-item parent-proxy measure of child quality of life, with versions specific to child age (2-4 years, 5-7 years) that each result in standardized total scores and domain-specific scores of physical functioning, emotional functioning, social functioning, and school functioning
Baseline, 2 weeks post-intervention, 3-months post-intervention
Behavioral Pediatrics Feeding Assessment Scale (BPFAS)
Time Frame: Baseline, 2 weeks post-intervention, 3-months post-intervention
A 35-item parent-proxy report of child mealtime and feeding behavior
Baseline, 2 weeks post-intervention, 3-months post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dana Bakula, PhD, Children's Mercy Hosptial

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 27, 2023

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

July 1, 2025

Study Registration Dates

First Submitted

July 27, 2023

First Submitted That Met QC Criteria

August 14, 2023

First Posted (Actual)

August 21, 2023

Study Record Updates

Last Update Posted (Estimated)

April 15, 2024

Last Update Submitted That Met QC Criteria

April 12, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 00002540

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric Feeding Disorder, Chronic

Clinical Trials on Parent Acceptance and Commitment Therapy (PACT)

3
Subscribe